Compare BMY & UL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMY | UL |
|---|---|---|
| Founded | 1887 | 1930 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0B | 132.9B |
| IPO Year | 2006 | 1999 |
| Metric | BMY | UL |
|---|---|---|
| Price | $63.14 | $66.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 5 |
| Target Price | $65.25 | ★ $71.92 |
| AVG Volume (30 Days) | ★ 9.3M | 4.0M |
| Earning Date | 10-29-2026 | 07-28-2026 |
| Dividend Yield | ★ 3.97% | 3.22% |
| EPS Growth | ★ 178.46 | N/A |
| EPS | ★ 3.98 | N/A |
| Revenue | ★ $48,194,000,000.00 | N/A |
| Revenue This Year | $4.23 | $3.11 |
| Revenue Next Year | N/A | $4.84 |
| P/E Ratio | $15.87 | ★ $14.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $45.27 | $54.75 |
| 52 Week High | $68.64 | $74.98 |
| Indicator | BMY | UL |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 57.61 |
| Support Level | $59.94 | $60.05 |
| Resistance Level | $63.47 | $67.31 |
| Average True Range (ATR) | 1.68 | 0.90 |
| MACD | 0.11 | -0.05 |
| Stochastic Oscillator | 52.34 | 60.66 |
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.